View Gilead Sciences, Inc. (GILD) current and estimated P/E ratio data provided by Seeking Alpha.

**NM signifies a non meaningful value. A dash signifies the data is not available.

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the November 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Gilead’s chief commercial officer. “It’s a clear symbol of our commitment to ending the epidemic for everyone, everywhere.” The generic version of the drug could be available by late 2027 ...

Ireland based pharmaceutical company Gilead Sciences has said it will grant licences to six generic manufacturers to produce low cost lenacapavir, which has shown unprecedented efficacy at preventing ...

The drugmaker Gilead Sciences on Wednesday announced a plan to allow six generic pharmaceutical companies in Asia and North ...

Dear Valued Partner, Vetoquinol Canada is pleased to offer veterinarians across the country a new Flexadin Essential product portfolio, the latest evolution of the Flexadin brand, designed to better ...

Knight Therapeutics Inc., ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained ...

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced, that new clinical data supporting the ...

He described the iconic landmark as both a unifying symbol and “a beacon for what ... the exterior of the building to its original form; gild key decorative elements; clean masonry; replace ...

Delaware State Police are investigating a shooting that occurred in Capitol Park yesterday evening. On October 12, 2024, at ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.